Comparison of the BD GeneOhm VanR assay and a chromogenic agar-based culture method in screening for vancomycin-resistant enterococci in rectal specimens of pediatric hematology-oncology patients

Turkish Journal of Pediatrics

Volumn 57, Issue 2, 2015, Pages 161-166

  Devrim, Fatma ^a   Gülfidan, Gamze ^a   Gözmen, Salih ^a   Demirağ, Bengü ^a   Oymak, Yeşim ^a   Yaman, Yöntem ^a   Oruç, Yeliz ^a   Yaşar, Nevbahar ^a   Apa, Hurşit ^a   Bayram, Nuri ^a   Vergin, Canan ^a   Devrim, İlker ^a  

^a DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

BD GeneOhm VanR assay; Chromogenic agar based culture; Hematology oncology; Vancomycinresistant enterococci

Indexed keywords

CANCER EPIDEMIOLOGY; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TURNAROUND TIME; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; HOSPITALIZATION; IMMUNOCOMPROMISED PATIENT; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

AGAR;

ADOLESCENT; AGAR; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGY; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; SENSITIVITY AND SPECIFICITY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84949985214     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50: 59-69.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-442.
3. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007; 58: 163–170.
4. Fang H, Nord CE, Ullberg M. Screening for vancomycinresistant enterococci: results of a survey in Stockholm. APMIS 2010; 118: 413–417.
5. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008; 29: 996–1011.
6. Lu JJ, Perng CL, Chiueh TS, et al. Detection and typing of vancomycin-resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR. Epidemiol Infect 2001; 126: 357–363.
7. Jayaratne P, Rutherford C. Detection of clinically relevant genotypes of vancomycin-resistant enterococci in nosocomial surveillance specimens by PCR. J Clin Microbiol 1999; 37: 2090–2092.
8. Petrich AK, Luinstra KE, Groves D, Chernesky MA, Mahony JB. Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR. Mol Cell Probes 1999; 13: 275–281.
9. Roger M, Faucher MC, Forest P, St-Antoine P, Coutlée F. Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak. J Clin Microbiol 1999; 37: 3348–3349.
10. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 1434.
11. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycinresistant enterococcal bacteremia. Clin Infect Dis 2003; 37: 921–928.
12. Drews SJ, Johnson G, Gharabaghi F, et al. A 24-hour screening protocol for identification of vancomycinresistant Enterococcus faecium. J Clin Microbiol 2006; 44: 1578–1580.
13. Palladino S, Kay ID, Flexman JP, et al. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol 2003; 41: 2483–2486.
14. Sloan LM, Uhl JR, Vetter EA, et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 2004; 42: 2636–2643.
15. Stamper PD, Cai M, Lema C, Eskey K, Carroll KC. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J Clin Microbiol 2007; 45: 3360–3365.
16. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev 2007; 28: 179–194.
17. Satake S, Clark N, Rimland D, Nolte FS, Tenover FC. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J Clin Microbiol 1997; 35: 2325–2330.
18. Mak A, Miller MA, Chong G, Monczak Y. Comparison of PCR and culture for screening of vancomycin-resistant enterococci: highly disparate results for vanA and vanB. J Clin Microbiol 2009; 47: 4136–4137.
19. Ballard SA, Grabsch EA, Johnson PD, Grayson ML. Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother 2005; 49: 77–81.
20. Domingo M C, Huletsky A, Bernal A, et al. Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J Antimicrob Chemother 2005; 55: 466–474.
21. Cetinkaya Y, Falk PS. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686–707.
22. Grabsch EA, Chua K, Xie S, et al. Improved detection of vanB2-containing Enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol 2008; 46: 1961–1964.
23. Ligozzi M, Lo Cascio G, Fontana R. vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans. Antimicrob Agents Chemother 1998; 42: 2055–2059.
24. Power EG, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. vanA genes in vancomycinresistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995; 36: 595–606.
25. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 2008; 46: 668–674.
26. D’Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002; 34: 167–172.
27. Lleò MM, Bonato B, Signoretto C, Canepari P. Vancomycin resistance is maintained in enterococci in the viable but nonculturable state and after division is resumed. Antimicrob Agents Chemother 2003; 47: 1154–1156.
28. Grabsch EA, Ghaly-Derias S, Gao W, Howden BP. Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycinresistant enterococci from feces and rectal swabs. J Clin Microbiol 2008; 46: 4034–4036.
29. Kuch A, Stefaniuk E, Ozorowski T, Hryniewicz W. New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species. J Microbiol Methods 2009; 77: 124–126.
30. Usacheva EA, Ginocchio CC, Morgan M, et al. Prospective, multicenter evaluation of the BD GeneOhm VanR assay for direct, rapid detection of vancomycinresistant Enterococcus species in perianal and rectal specimens. Am J Clin Pathol 2010; 134: 219–226.